1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. MICRORNA MARKET BY TYPE
5.1. Introduction
5.2. Products
5.3. Services
6. MICRORNA MARKET BY APPLICATION
6.1. Introduction
6.2. Cancer
6.3. Infectious Diseases
6.4. Immunological Disorder
6.5. Cardiovascular Disease
6.6. Neurological Disease
6.7. Others
7. MICRORNA MARKET BY END-USER
7.1. Introduction
7.2. Biotechnology & Pharmaceutical Companies
7.3. Academic & Government Research Institutes
7.4. Other end-users
8. MICRORNA MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Thermo Fisher Scientific, Inc.
10.2. Horizon Discovery Ltd.
10.3. QIAGEN
10.4. BioGenex
10.5. GeneCopoeia, Inc.
10.6. NanoString
10.7. Quantabio
10.8. SeqMatic LLC
10.9. OriGene Technologies, Inc.
10.10. Illumina, Inc.
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES